Kangstem Biotech Co. Ltd (217730) — Financial Flexibility Index
Kangstem Biotech Co. Ltd (217730) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of ₩-3.77 Billion (operating CF ₩-3.81 Billion minus capex ₩34.65 Million) represents 0% of total liabilities (₩11.60 Billion). Also explore Kangstem Biotech Co. Ltd (217730) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kangstem Biotech Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Kangstem Biotech Co. Ltd across 10 annual periods. Check asset allocation strategy of Kangstem Biotech Co. Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kangstem Biotech Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Kangstem Biotech Co. Ltd. For the full company profile including market capitalisation, see Kangstem Biotech Co. Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.44x | ₩-18.39 Billion | ₩-18.99 Billion | ₩12.80 Billion | ▼ -249.7% |
| 2023 | -0.41x | ₩-15.09 Billion | ₩-16.50 Billion | ₩36.74 Billion | ▲ +24.6% |
| 2022 | -0.54x | ₩-18.15 Billion | ₩-18.86 Billion | ₩33.33 Billion | ▼ -54.5% |
| 2021 | -0.35x | ₩-12.36 Billion | ₩-16.99 Billion | ₩35.07 Billion | ▲ +0.6% |
| 2020 | -0.35x | ₩-10.96 Billion | ₩-13.99 Billion | ₩30.89 Billion | ▼ -853.4% |
| 2019 | 0.05x | ₩2.02 Billion | ₩-13.32 Billion | ₩42.92 Billion | ▲ +112.2% |
| 2018 | -0.39x | ₩-9.87 Billion | ₩-11.48 Billion | ₩25.50 Billion | ▼ -243.7% |
| 2017 | -0.11x | ₩-2.53 Billion | ₩-10.65 Billion | ₩22.44 Billion | ▲ +55.0% |
| 2016 | -0.25x | ₩-6.12 Billion | ₩-7.80 Billion | ₩24.46 Billion | ▲ +66.1% |
| 2015 | -0.74x | ₩-2.76 Billion | ₩-3.80 Billion | ₩3.75 Billion | — |